Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Molecular Immunology
Britta Blumenthal has not added Biography.
If you are Britta Blumenthal and would like to personalize this page please email our Author Liaison for assistance.
The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol.
Infection and immunity Jul, 2007 | Pubmed ID: 17438028
Cleavage of Escherichia coli cytotoxic necrotizing factor 1 is required for full biologic activity.
Infection and immunity May, 2009 | Pubmed ID: 19237521
5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo.
PloS one , 2009 | Pubmed ID: 19649285
Detection of phosphorylated T and B cell antigen receptor species by Phos-tag SDS- and Blue Native-PAGE.
Immunology letters May, 2010 | Pubmed ID: 20005898
Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function.
Artificial organs Feb, 2010 | Pubmed ID: 20420589
A potential role for P2X7R in allergic airway inflammation in mice and humans.
American journal of respiratory cell and molecular biology Apr, 2011 | Pubmed ID: 20508067
Scaffold-based transplantation of akt1-overexpressing skeletal myoblasts: functional regeneration is associated with angiogenesis and reduced infarction size.
Tissue engineering. Part A Jan, 2011 | Pubmed ID: 20695763
Functional regeneration of ischemic myocardium by transplanted cells overexpressing stromal cell-derived factor-1 (SDF-1): intramyocardial injection versus scaffold-based application.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery Oct, 2011 | Pubmed ID: 21684755
Hepatocyte Growth Factor-Transfected Skeletal Myoblasts to Limit the Development of Postinfarction Heart Failure.
Artificial organs Sep, 2011 | Pubmed ID: 21899570
Max-Planck-Institute of Immunology and Epigenetics
Gina J. Fiala1,2,3,
Wolfgang W. A. Schamel*,2,3,
Britta Blumenthal*,3
1Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg,
2Centre for Biological Signalling Studies (bioss) and Biology III, Faculty of Biology, University of Freiburg,
3Department of Molecular Immunology, Max-Planck-Institute of Immunology and Epigenetics
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados